Trial Profile
A phase I dose escalation, pharmacodynamic trial of semaxanib (SU5416) combined with weekly cisplatin and irinotecan in patients with advanced solid tumor
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Semaxanib (Primary) ; Cisplatin; Irinotecan
- Indications Solid tumours
- Focus Pharmacodynamics; Pharmacokinetics
- 28 Nov 2015 New trial record